UniProt ID | NASP_HUMAN | |
---|---|---|
UniProt AC | P49321 | |
Protein Name | Nuclear autoantigenic sperm protein | |
Gene Name | NASP | |
Organism | Homo sapiens (Human). | |
Sequence Length | 788 | |
Subcellular Localization | Cytoplasm . Nucleus . | |
Protein Description | Required for DNA replication, normal cell cycle progression and cell proliferation. Forms a cytoplasmic complex with HSP90 and H1 linker histones and stimulates HSP90 ATPase activity. NASP and H1 histone are subsequently released from the complex and translocate to the nucleus where the histone is released for binding to DNA.. | |
Protein Sequence | MAMESTATAAVAAELVSADKIEDVPAPSTSADKVESLDVDSEAKKLLGLGQKHLVMGDIPAAVNAFQEAASLLGKKYGETANECGEAFFFYGKSLLELARMENGVLGNALEGVHVEEEEGEKTEDESLVENNDNIDEEAREELREQVYDAMGEKEEAKKTEDKSLAKPETDKEQDSEMEKGGREDMDISKSAEEPQEKVDLTLDWLTETSEEAKGGAAPEGPNEAEVTSGKPEQEVPDAEEEKSVSGTDVQEECREKGGQEKQGEVIVSIEEKPKEVSEEQPVVTLEKQGTAVEVEAESLDPTVKPVDVGGDEPEEKVVTSENEAGKAVLEQLVGQEVPPAEESPEVTTEAAEASAVEAGSEVSEKPGQEAPVLPKDGAVNGPSVVGDQTPIEPQTSIERLTETKDGSGLEEKVRAKLVPSQEETKLSVEESEAAGDGVDTKVAQGATEKSPEDKVQIAANEETQEREEQMKEGEETEGSEEDDKENDKTEEMPNDSVLENKSLQENEEEEIGNLELAWDMLDLAKIIFKRQETKEAQLYAAQAHLKLGEVSVESENYVQAVEEFQSCLNLQEQYLEAHDRLLAETHYQLGLAYGYNSQYDEAVAQFSKSIEVIENRMAVLNEQVKEAEGSSAEYKKEIEELKELLPEIREKIEDAKESQRSGNVAELALKATLVESSTSGFTPGGGGSSVSMIASRKPTDGASSSNCVTDISHLVRKKRKPEEESPRKDDAKKAKQEPEVNGGSGDAVPSGNEVSENMEEEAENQAESRAAVEGTVEAGATVESTAC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAMESTATA ------CCCCHHHHH | 15.51 | 22223895 | |
17 | Phosphorylation | AVAAELVSADKIEDV HHHHHHHCCHHCCCC | 43.29 | 26074081 | |
20 | Acetylation | AELVSADKIEDVPAP HHHHCCHHCCCCCCC | 47.95 | 30585385 | |
28 | Phosphorylation | IEDVPAPSTSADKVE CCCCCCCCCCCHHCC | 36.78 | 28450419 | |
29 | Phosphorylation | EDVPAPSTSADKVES CCCCCCCCCCHHCCC | 27.20 | 28450419 | |
30 | Phosphorylation | DVPAPSTSADKVESL CCCCCCCCCHHCCCC | 38.52 | 21815630 | |
33 | Acetylation | APSTSADKVESLDVD CCCCCCHHCCCCCCC | 47.85 | 19608861 | |
33 | Ubiquitination | APSTSADKVESLDVD CCCCCCHHCCCCCCC | 47.85 | 19608861 | |
33 (in isoform 1) | Ubiquitination | - | 47.85 | 21890473 | |
33 (in isoform 2) | Ubiquitination | - | 47.85 | 21890473 | |
33 (in isoform 4) | Acetylation | - | 47.85 | - | |
36 | Phosphorylation | TSADKVESLDVDSEA CCCHHCCCCCCCHHH | 32.62 | 25159151 | |
41 | Phosphorylation | VESLDVDSEAKKLLG CCCCCCCHHHHHHHC | 39.02 | 27732954 | |
44 | 2-Hydroxyisobutyrylation | LDVDSEAKKLLGLGQ CCCCHHHHHHHCCCC | 39.64 | - | |
45 | Ubiquitination | DVDSEAKKLLGLGQK CCCHHHHHHHCCCCC | 56.86 | 21890473 | |
45 | Ubiquitination | DVDSEAKKLLGLGQK CCCHHHHHHHCCCCC | 56.86 | 21890473 | |
45 (in isoform 1) | Ubiquitination | - | 56.86 | 21890473 | |
45 (in isoform 2) | Ubiquitination | - | 56.86 | 21890473 | |
47 (in isoform 3) | Ubiquitination | - | 7.95 | 21890473 | |
52 | Ubiquitination | KLLGLGQKHLVMGDI HHHCCCCCEEECCCH | 36.79 | 21906983 | |
52 (in isoform 1) | Ubiquitination | - | 36.79 | 21890473 | |
52 (in isoform 2) | Ubiquitination | - | 36.79 | 21890473 | |
54 (in isoform 3) | Ubiquitination | - | 3.50 | 21890473 | |
71 | Phosphorylation | NAFQEAASLLGKKYG HHHHHHHHHHCHHHC | 31.04 | 25159151 | |
75 | 2-Hydroxyisobutyrylation | EAASLLGKKYGETAN HHHHHHCHHHCCHHH | 42.67 | - | |
75 | Ubiquitination | EAASLLGKKYGETAN HHHHHHCHHHCCHHH | 42.67 | - | |
76 | Ubiquitination | AASLLGKKYGETANE HHHHHCHHHCCHHHH | 57.60 | - | |
77 | Phosphorylation | ASLLGKKYGETANEC HHHHCHHHCCHHHHH | 24.55 | 28152594 | |
78 (in isoform 3) | Ubiquitination | - | 34.36 | - | |
84 | Glutathionylation | YGETANECGEAFFFY HCCHHHHHHHHHHHH | 6.31 | 22555962 | |
93 | Ubiquitination | EAFFFYGKSLLELAR HHHHHHHHHHHHHHH | 26.93 | 21906983 | |
93 (in isoform 1) | Ubiquitination | - | 26.93 | 21890473 | |
93 (in isoform 2) | Ubiquitination | - | 26.93 | 21890473 | |
94 | Phosphorylation | AFFFYGKSLLELARM HHHHHHHHHHHHHHH | 33.55 | 21712546 | |
95 (in isoform 3) | Ubiquitination | - | 4.99 | 21890473 | |
123 | Phosphorylation | EEEEGEKTEDESLVE CHHCCCCCCCHHHHC | 44.35 | 19664994 | |
123 (in isoform 2) | Phosphorylation | - | 44.35 | 20068231 | |
127 | Phosphorylation | GEKTEDESLVENNDN CCCCCCHHHHCCCCC | 50.46 | 19664994 | |
127 (in isoform 2) | Phosphorylation | - | 50.46 | 20068231 | |
138 (in isoform 2) | Phosphorylation | - | 49.64 | 28355574 | |
140 | Methylation | DNIDEEAREELREQV CCCCHHHHHHHHHHH | 41.00 | 115484511 | |
141 (in isoform 2) | Phosphorylation | - | 69.31 | 26503892 | |
148 | Phosphorylation | EELREQVYDAMGEKE HHHHHHHHHHHCCHH | 9.55 | 25884760 | |
151 (in isoform 2) | Phosphorylation | - | 6.95 | 25159151 | |
154 | Acetylation | VYDAMGEKEEAKKTE HHHHHCCHHHHHHHC | 55.94 | 23954790 | |
158 (in isoform 2) | Phosphorylation | - | 64.60 | 23909892 | |
164 | Phosphorylation | AKKTEDKSLAKPETD HHHHCCCCCCCCCCC | 45.97 | 19664994 | |
169 (in isoform 3) | Ubiquitination | - | 69.77 | - | |
170 | Phosphorylation | KSLAKPETDKEQDSE CCCCCCCCCHHHHHH | 61.98 | 29255136 | |
176 | Phosphorylation | ETDKEQDSEMEKGGR CCCHHHHHHHHHCCH | 38.24 | 29255136 | |
180 | Acetylation | EQDSEMEKGGREDMD HHHHHHHHCCHHCCC | 66.41 | 23236377 | |
189 | Phosphorylation | GREDMDISKSAEEPQ CHHCCCCHHCCCCCH | 19.12 | 23401153 | |
191 | Phosphorylation | EDMDISKSAEEPQEK HCCCCHHCCCCCHHH | 33.84 | 21712546 | |
196 (in isoform 2) | Ubiquitination | - | 67.43 | 21890473 | |
202 | Phosphorylation | PQEKVDLTLDWLTET CHHHHCCCHHHHHCC | 20.43 | 30301811 | |
207 | Phosphorylation | DLTLDWLTETSEEAK CCCHHHHHCCCHHHC | 32.72 | 27732954 | |
209 | Phosphorylation | TLDWLTETSEEAKGG CHHHHHCCCHHHCCC | 35.88 | 27732954 | |
210 | Phosphorylation | LDWLTETSEEAKGGA HHHHHCCCHHHCCCC | 27.49 | 19664994 | |
228 | Phosphorylation | GPNEAEVTSGKPEQE CCCCCCCCCCCCCCC | 24.22 | 25159151 | |
229 | Phosphorylation | PNEAEVTSGKPEQEV CCCCCCCCCCCCCCC | 50.42 | 25159151 | |
231 | Acetylation | EAEVTSGKPEQEVPD CCCCCCCCCCCCCCC | 45.19 | 23236377 | |
231 | Ubiquitination | EAEVTSGKPEQEVPD CCCCCCCCCCCCCCC | 45.19 | 21906983 | |
231 (in isoform 1) | Ubiquitination | - | 45.19 | 21890473 | |
233 (in isoform 3) | Ubiquitination | - | 63.96 | 21890473 | |
243 | Acetylation | VPDAEEEKSVSGTDV CCCHHHHHCCCCCHH | 60.48 | - | |
244 | Phosphorylation | PDAEEEKSVSGTDVQ CCHHHHHCCCCCHHH | 25.46 | 19664994 | |
246 | Phosphorylation | AEEEKSVSGTDVQEE HHHHHCCCCCHHHHH | 42.96 | 19664994 | |
248 | Phosphorylation | EEKSVSGTDVQEECR HHHCCCCCHHHHHHH | 26.03 | 19664994 | |
269 | Phosphorylation | KQGEVIVSIEEKPKE CCCEEEEEEECCCCC | 17.10 | 28348404 | |
278 | Phosphorylation | EEKPKEVSEEQPVVT ECCCCCCCCCCCCEE | 36.19 | 25849741 | |
285 | Phosphorylation | SEEQPVVTLEKQGTA CCCCCCEEEEECCEE | 29.45 | 21406692 | |
287 (in isoform 2) | Ubiquitination | - | 33.69 | 21890473 | |
288 | Acetylation | QPVVTLEKQGTAVEV CCCEEEEECCEEEEE | 58.08 | - | |
291 | O-linked_Glycosylation | VTLEKQGTAVEVEAE EEEEECCEEEEEEEH | 25.65 | 23301498 | |
291 | Phosphorylation | VTLEKQGTAVEVEAE EEEEECCEEEEEEEH | 25.65 | 28464451 | |
298 (in isoform 2) | Ubiquitination | - | 38.03 | 21890473 | |
299 | Phosphorylation | AVEVEAESLDPTVKP EEEEEEHHCCCCCCC | 45.15 | 25159151 | |
303 | Phosphorylation | EAESLDPTVKPVDVG EEHHCCCCCCCCCCC | 40.61 | 23403867 | |
304 (in isoform 2) | Ubiquitination | - | 8.86 | 21890473 | |
313 (in isoform 2) | Ubiquitination | - | 58.86 | 21890473 | |
318 (in isoform 2) | Ubiquitination | - | 6.85 | 21890473 | |
320 | Phosphorylation | EPEEKVVTSENEAGK CCCHHEECCCCHHHH | 33.05 | 25850435 | |
321 | Phosphorylation | PEEKVVTSENEAGKA CCHHEECCCCHHHHH | 27.15 | 29255136 | |
332 (in isoform 2) | Ubiquitination | - | 36.97 | 21890473 | |
344 | Phosphorylation | EVPPAEESPEVTTEA CCCCCHHCCCCCHHH | 20.19 | 28464451 | |
348 | Phosphorylation | AEESPEVTTEAAEAS CHHCCCCCHHHHHHH | 19.77 | 25627689 | |
349 | Phosphorylation | EESPEVTTEAAEASA HHCCCCCHHHHHHHH | 28.89 | 28464451 | |
361 | Phosphorylation | ASAVEAGSEVSEKPG HHHHHCCCCCCCCCC | 41.70 | 22210691 | |
384 | Phosphorylation | DGAVNGPSVVGDQTP CCCCCCCCCCCCCCC | 30.73 | 30266825 | |
390 | Phosphorylation | PSVVGDQTPIEPQTS CCCCCCCCCCCCCCC | 30.85 | 30266825 | |
396 | Phosphorylation | QTPIEPQTSIERLTE CCCCCCCCCHHHHHC | 42.24 | 30266825 | |
397 | Phosphorylation | TPIEPQTSIERLTET CCCCCCCCHHHHHCC | 19.73 | 30266825 | |
402 | Phosphorylation | QTSIERLTETKDGSG CCCHHHHHCCCCCCC | 48.07 | 28450419 | |
404 | Phosphorylation | SIERLTETKDGSGLE CHHHHHCCCCCCCHH | 29.24 | 28450419 | |
405 | Ubiquitination | IERLTETKDGSGLEE HHHHHCCCCCCCHHH | 54.59 | - | |
408 | O-linked_Glycosylation | LTETKDGSGLEEKVR HHCCCCCCCHHHHHH | 50.79 | 23301498 | |
408 | Phosphorylation | LTETKDGSGLEEKVR HHCCCCCCCHHHHHH | 50.79 | 21712546 | |
413 | Ubiquitination | DGSGLEEKVRAKLVP CCCCHHHHHHHEECC | 27.87 | - | |
417 | Acetylation | LEEKVRAKLVPSQEE HHHHHHHEECCCHHH | 39.18 | 23954790 | |
417 | Ubiquitination | LEEKVRAKLVPSQEE HHHHHHHEECCCHHH | 39.18 | - | |
421 | Phosphorylation | VRAKLVPSQEETKLS HHHEECCCHHHHCCC | 42.62 | 29255136 | |
425 | Phosphorylation | LVPSQEETKLSVEES ECCCHHHHCCCHHHH | 36.21 | 30266825 | |
426 | Ubiquitination | VPSQEETKLSVEESE CCCHHHHCCCHHHHH | 41.88 | - | |
428 | Phosphorylation | SQEETKLSVEESEAA CHHHHCCCHHHHHHC | 29.10 | 30266825 | |
428 (in isoform 3) | Ubiquitination | - | 29.10 | - | |
432 | Phosphorylation | TKLSVEESEAAGDGV HCCCHHHHHHCCCCC | 21.01 | 30266825 | |
441 | Phosphorylation | AAGDGVDTKVAQGAT HCCCCCCCCHHCCCC | 25.63 | 20873877 | |
442 | Ubiquitination | AGDGVDTKVAQGATE CCCCCCCCHHCCCCC | 30.98 | 21906983 | |
442 (in isoform 1) | Ubiquitination | - | 30.98 | 21890473 | |
444 (in isoform 3) | Ubiquitination | - | 12.02 | 21890473 | |
448 | Phosphorylation | TKVAQGATEKSPEDK CCHHCCCCCCCHHHH | 51.26 | 30266825 | |
450 | Acetylation | VAQGATEKSPEDKVQ HHCCCCCCCHHHHHH | 67.94 | 25953088 | |
451 | Phosphorylation | AQGATEKSPEDKVQI HCCCCCCCHHHHHHH | 27.56 | 29255136 | |
455 | Acetylation | TEKSPEDKVQIAANE CCCCHHHHHHHHCCH | 34.08 | 23954790 | |
464 | Phosphorylation | QIAANEETQEREEQM HHHCCHHHHHHHHHH | 29.56 | 19664994 | |
477 | Phosphorylation | QMKEGEETEGSEEDD HHHHHCCCCCCCCCC | 41.15 | 20201521 | |
480 | Phosphorylation | EGEETEGSEEDDKEN HHCCCCCCCCCCCCC | 31.42 | 20201521 | |
490 | Phosphorylation | DDKENDKTEEMPNDS CCCCCCCCCCCCCCH | 39.79 | 30266825 | |
497 | Phosphorylation | TEEMPNDSVLENKSL CCCCCCCHHHCCCCC | 34.93 | 25159151 | |
503 | Phosphorylation | DSVLENKSLQENEEE CHHHCCCCCCCCCHH | 47.03 | 19664994 | |
534 | Phosphorylation | IIFKRQETKEAQLYA HHHHCCCHHHHHHHH | 26.33 | 30624053 | |
535 | Ubiquitination | IFKRQETKEAQLYAA HHHCCCHHHHHHHHH | 50.75 | 21890473 | |
535 | Ubiquitination | IFKRQETKEAQLYAA HHHCCCHHHHHHHHH | 50.75 | 21890473 | |
535 (in isoform 1) | Ubiquitination | - | 50.75 | 21890473 | |
537 (in isoform 3) | Ubiquitination | - | 13.26 | 21890473 | |
540 | Nitration | ETKEAQLYAAQAHLK CHHHHHHHHHHHHHH | 6.44 | - | |
540 | Phosphorylation | ETKEAQLYAAQAHLK CHHHHHHHHHHHHHH | 6.44 | 28152594 | |
567 | Phosphorylation | QAVEEFQSCLNLQEQ HHHHHHHHHHHHHHH | 26.37 | - | |
575 | Phosphorylation | CLNLQEQYLEAHDRL HHHHHHHHHHHHHHH | 13.03 | - | |
598 | Phosphorylation | GLAYGYNSQYDEAVA HCCCCCCHHHHHHHH | 22.95 | - | |
608 | O-linked_Glycosylation | DEAVAQFSKSIEVIE HHHHHHHHHHHHHHH | 17.26 | 23301498 | |
610 | Phosphorylation | AVAQFSKSIEVIENR HHHHHHHHHHHHHHH | 23.84 | 27732954 | |
617 | Methylation | SIEVIENRMAVLNEQ HHHHHHHHHHHHHHH | 11.14 | 115484503 | |
618 | Sulfoxidation | IEVIENRMAVLNEQV HHHHHHHHHHHHHHH | 4.57 | 21406390 | |
626 | Ubiquitination | AVLNEQVKEAEGSSA HHHHHHHHHHCCCCH | 51.40 | 21906983 | |
626 (in isoform 1) | Ubiquitination | - | 51.40 | 21890473 | |
628 (in isoform 3) | Ubiquitination | - | 22.26 | 21890473 | |
631 | Phosphorylation | QVKEAEGSSAEYKKE HHHHHCCCCHHHHHH | 20.20 | 21815630 | |
632 | Phosphorylation | VKEAEGSSAEYKKEI HHHHCCCCHHHHHHH | 35.66 | 28985074 | |
635 | Phosphorylation | AEGSSAEYKKEIEEL HCCCCHHHHHHHHHH | 27.38 | 28985074 | |
636 | Sumoylation | EGSSAEYKKEIEELK CCCCHHHHHHHHHHH | 35.12 | - | |
636 | Acetylation | EGSSAEYKKEIEELK CCCCHHHHHHHHHHH | 35.12 | 25953088 | |
636 | Sumoylation | EGSSAEYKKEIEELK CCCCHHHHHHHHHHH | 35.12 | - | |
637 | Ubiquitination | GSSAEYKKEIEELKE CCCHHHHHHHHHHHH | 64.12 | 21890473 | |
637 | 2-Hydroxyisobutyrylation | GSSAEYKKEIEELKE CCCHHHHHHHHHHHH | 64.12 | - | |
637 | Ubiquitination | GSSAEYKKEIEELKE CCCHHHHHHHHHHHH | 64.12 | 21890473 | |
637 (in isoform 1) | Ubiquitination | - | 64.12 | 21890473 | |
639 (in isoform 3) | Ubiquitination | - | 7.37 | 21890473 | |
643 | Ubiquitination | KKEIEELKELLPEIR HHHHHHHHHHHHHHH | 49.98 | 21890473 | |
643 | 2-Hydroxyisobutyrylation | KKEIEELKELLPEIR HHHHHHHHHHHHHHH | 49.98 | - | |
643 | Acetylation | KKEIEELKELLPEIR HHHHHHHHHHHHHHH | 49.98 | 23954790 | |
643 | Ubiquitination | KKEIEELKELLPEIR HHHHHHHHHHHHHHH | 49.98 | 21890473 | |
643 (in isoform 1) | Ubiquitination | - | 49.98 | 21890473 | |
645 (in isoform 3) | Ubiquitination | - | 10.39 | 21890473 | |
652 | Ubiquitination | LLPEIREKIEDAKES HHHHHHHHHHHHHHH | 41.36 | 21906983 | |
652 (in isoform 1) | Ubiquitination | - | 41.36 | 21890473 | |
654 (in isoform 3) | Ubiquitination | - | 64.08 | 21890473 | |
657 | Succinylation | REKIEDAKESQRSGN HHHHHHHHHHHHCCC | 70.94 | 23954790 | |
657 | Ubiquitination | REKIEDAKESQRSGN HHHHHHHHHHHHCCC | 70.94 | - | |
657 (in isoform 1) | Ubiquitination | - | 70.94 | 21890473 | |
659 | Phosphorylation | KIEDAKESQRSGNVA HHHHHHHHHHCCCHH | 30.13 | 25159151 | |
659 (in isoform 3) | Ubiquitination | - | 30.13 | 21890473 | |
662 | Phosphorylation | DAKESQRSGNVAELA HHHHHHHCCCHHHHH | 27.38 | 25159151 | |
671 | Ubiquitination | NVAELALKATLVESS CHHHHHHHHHEEECC | 33.45 | 2190698 | |
671 (in isoform 1) | Ubiquitination | - | 33.45 | 21890473 | |
673 | O-linked_Glycosylation | AELALKATLVESSTS HHHHHHHHEEECCCC | 29.74 | 23301498 | |
673 | Phosphorylation | AELALKATLVESSTS HHHHHHHHEEECCCC | 29.74 | 27080861 | |
673 (in isoform 3) | Ubiquitination | - | 29.74 | 21890473 | |
677 | O-linked_Glycosylation | LKATLVESSTSGFTP HHHHEEECCCCCCCC | 31.28 | 23301498 | |
677 | Phosphorylation | LKATLVESSTSGFTP HHHHEEECCCCCCCC | 31.28 | 30576142 | |
678 | O-linked_Glycosylation | KATLVESSTSGFTPG HHHEEECCCCCCCCC | 17.06 | 23301498 | |
678 | Phosphorylation | KATLVESSTSGFTPG HHHEEECCCCCCCCC | 17.06 | 29978859 | |
679 | O-linked_Glycosylation | ATLVESSTSGFTPGG HHEEECCCCCCCCCC | 41.99 | 23301498 | |
679 | Phosphorylation | ATLVESSTSGFTPGG HHEEECCCCCCCCCC | 41.99 | 25850435 | |
680 | O-linked_Glycosylation | TLVESSTSGFTPGGG HEEECCCCCCCCCCC | 33.58 | 23301498 | |
680 | Phosphorylation | TLVESSTSGFTPGGG HEEECCCCCCCCCCC | 33.58 | 30576142 | |
683 | O-linked_Glycosylation | ESSTSGFTPGGGGSS ECCCCCCCCCCCCCC | 25.25 | 23301498 | |
683 | Phosphorylation | ESSTSGFTPGGGGSS ECCCCCCCCCCCCCC | 25.25 | 25159151 | |
689 | O-linked_Glycosylation | FTPGGGGSSVSMIAS CCCCCCCCCCHHEEE | 30.73 | 23301498 | |
689 | Phosphorylation | FTPGGGGSSVSMIAS CCCCCCCCCCHHEEE | 30.73 | 25850435 | |
690 | Phosphorylation | TPGGGGSSVSMIASR CCCCCCCCCHHEEEC | 22.83 | 25850435 | |
692 | Phosphorylation | GGGGSSVSMIASRKP CCCCCCCHHEEECCC | 13.35 | 26074081 | |
693 | Sulfoxidation | GGGSSVSMIASRKPT CCCCCCHHEEECCCC | 2.51 | 30846556 | |
696 | Phosphorylation | SSVSMIASRKPTDGA CCCHHEEECCCCCCC | 29.88 | 26074081 | |
698 | Acetylation | VSMIASRKPTDGASS CHHEEECCCCCCCCC | 50.18 | 23749302 | |
698 | Ubiquitination | VSMIASRKPTDGASS CHHEEECCCCCCCCC | 50.18 | - | |
700 | Phosphorylation | MIASRKPTDGASSSN HEEECCCCCCCCCCC | 50.53 | 23401153 | |
700 (in isoform 3) | Ubiquitination | - | 50.53 | - | |
704 | Phosphorylation | RKPTDGASSSNCVTD CCCCCCCCCCCHHHH | 39.57 | 23401153 | |
705 | Phosphorylation | KPTDGASSSNCVTDI CCCCCCCCCCHHHHH | 25.65 | 30266825 | |
706 | Phosphorylation | PTDGASSSNCVTDIS CCCCCCCCCHHHHHH | 31.58 | 30266825 | |
708 | Glutathionylation | DGASSSNCVTDISHL CCCCCCCHHHHHHHH | 3.63 | 22555962 | |
710 | O-linked_Glycosylation | ASSSNCVTDISHLVR CCCCCHHHHHHHHHH | 29.80 | OGP | |
710 | Phosphorylation | ASSSNCVTDISHLVR CCCCCHHHHHHHHHH | 29.80 | 30266825 | |
713 | Phosphorylation | SNCVTDISHLVRKKR CCHHHHHHHHHHHCC | 17.36 | 23403867 | |
721 | Methylation | HLVRKKRKPEEESPR HHHHHCCCCCCCCCC | 66.71 | 116252357 | |
726 | Phosphorylation | KRKPEEESPRKDDAK CCCCCCCCCCHHHHH | 33.03 | 29255136 | |
733 | Acetylation | SPRKDDAKKAKQEPE CCCHHHHHHHHCCCC | 61.33 | 7481363 | |
734 | Acetylation | PRKDDAKKAKQEPEV CCHHHHHHHHCCCCC | 63.64 | 6570403 | |
736 | Acetylation | KDDAKKAKQEPEVNG HHHHHHHHCCCCCCC | 65.16 | 23236377 | |
736 | Sumoylation | KDDAKKAKQEPEVNG HHHHHHHHCCCCCCC | 65.16 | 25114211 | |
745 | Phosphorylation | EPEVNGGSGDAVPSG CCCCCCCCCCCCCCC | 34.59 | 30576142 | |
751 | Phosphorylation | GSGDAVPSGNEVSEN CCCCCCCCCCHHCHH | 47.88 | 28102081 | |
756 | Phosphorylation | VPSGNEVSENMEEEA CCCCCHHCHHHHHHH | 19.64 | 29978859 | |
769 | Phosphorylation | EAENQAESRAAVEGT HHHHHHHHHHHHHCE | 30.18 | 22210691 | |
782 | Phosphorylation | GTVEAGATVESTAC- CEECCCCEEEECCC- | 24.72 | 22817901 | |
785 | Phosphorylation | EAGATVESTAC---- CCCCEEEECCC---- | 19.57 | 22817901 | |
788 | Glutathionylation | ATVESTAC------- CEEEECCC------- | 6.08 | 22555962 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
158 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NASP_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NASP_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
H32_HUMAN | HIST2H3C | physical | 16189514 | |
LC7L2_HUMAN | LUC7L2 | physical | 16169070 | |
H31_HUMAN | HIST1H3A | physical | 20167597 | |
AIRE_HUMAN | AIRE | physical | 20085707 | |
TERA_HUMAN | VCP | physical | 22939629 | |
STIP1_HUMAN | STIP1 | physical | 22939629 | |
ERF3B_HUMAN | GSPT2 | physical | 22863883 | |
H3C_HUMAN | H3F3C | physical | 25416956 | |
DKC1_HUMAN | DKC1 | physical | 26344197 | |
RBBP4_HUMAN | RBBP4 | physical | 26496610 | |
RBBP7_HUMAN | RBBP7 | physical | 26496610 | |
KCAB2_HUMAN | KCNAB2 | physical | 26496610 | |
HAT1_HUMAN | HAT1 | physical | 26496610 | |
ASF1A_HUMAN | ASF1A | physical | 26496610 | |
S43A3_HUMAN | SLC43A3 | physical | 26496610 | |
DONS_HUMAN | DONSON | physical | 26496610 | |
ASF1B_HUMAN | ASF1B | physical | 26496610 | |
PYRG2_HUMAN | CTPS2 | physical | 26496610 | |
KLF16_HUMAN | KLF16 | physical | 26496610 | |
H2A1_YEAST | HTA1 | physical | 27618665 | |
H2B1_YEAST | HTB1 | physical | 27618665 | |
H3_YEAST | HHT1 | physical | 27618665 | |
H4_YEAST | HHF1 | physical | 27618665 | |
EKI1_HUMAN | ETNK1 | physical | 28514442 | |
RBBP4_HUMAN | RBBP4 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-30; SER-421 AND SER-497, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-33, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-390 AND SER-503, ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-30; SER-421 AND SER-497, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-189; SER-244; THR-390;SER-408 AND THR-683, AND MASS SPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-421; SER-451 ANDTHR-464, AND MASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-228; THR-390; THR-477;SER-480; SER-497 AND SER-726, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-189; SER-244; SER-451;THR-477; SER-480; SER-503 AND SER-726, AND MASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-390 AND SER-421, ANDMASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-390, AND MASSSPECTROMETRY. |